Promega Developing OncoMate™ MSI Assay as Companion Diagnostic for Endometrial Cancer Drug Candidate from Incyte
MADISON, Wis.--(BUSINESS WIRE)--Promega Corporation announced today its intent to develop the Promega OncoMate™ microsatellite instability…